Adaptive Biotechnologies Corp vs Alliant Energy Corporation — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Alliant Energy Corporation trades at $68.76 (market cap $17.78B). The key difference: Alliant Energy Corporation is far larger — about 4.4× Adaptive Biotechnologies Corp's market cap, and Alliant Energy Corporation pays a 3.12% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | LNT | |
|---|---|---|
Market Cap | $4.04B | $17.78B |
Sector | Health | Utilities |
52-Week High | $25.45 | $78.03 |
52-Week Low | $12.30 | $63.62 |
Enterprise Value | $4.10B | $29.88B |
Dividend Yield | — | 3.12% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →